|
|
Volumn 17, Issue 1, 2017, Pages 18-
|
|
Nivolumab plus interferon-γ in the treatment of intractable mucormycosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B LIPID COMPLEX;
GAMMA INTERFERON;
HLA DR ANTIGEN;
NIVOLUMAB;
POSACONAZOLE;
IMMUNOLOGICAL ADJUVANT;
MONOCLONAL ANTIBODY;
ADULT;
BURN;
CASE REPORT;
CD8+ T LYMPHOCYTE;
COMPUTER ASSISTED TOMOGRAPHY;
FEMALE;
FEMUR FRACTURE;
GASTRECTOMY;
HLA SYSTEM;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INTENSIVE CARE UNIT;
INTRACTABLE MUCORMYCOSIS;
LETTER;
LUNG CONTUSION;
LYMPHOCYTE COUNT;
MEDICAL HISTORY;
MUCORMYCOSIS;
PELVIS FRACTURE;
PRIORITY JOURNAL;
PROGNOSIS;
SPLENECTOMY;
STOMACH BIOPSY;
ABDOMEN;
COMBINATION DRUG THERAPY;
DIAGNOSTIC IMAGING;
FUNGEMIA;
IMMUNIZATION;
MICROBIOLOGY;
SPLEEN;
STOMACH;
X-RAY COMPUTED TOMOGRAPHY;
ABDOMEN;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
ANTIBODIES, MONOCLONAL;
DRUG THERAPY, COMBINATION;
FEMALE;
FUNGEMIA;
GASTRECTOMY;
HUMANS;
IMMUNIZATION;
INTERFERON-GAMMA;
MUCORMYCOSIS;
SPLEEN;
SPLENECTOMY;
STOMACH;
TOMOGRAPHY, X-RAY COMPUTED;
|
|
EID: 85008154354
PISSN: 14733099
EISSN: 14744457
Source Type: Journal
DOI: 10.1016/S1473-3099(16)30541-2 Document Type: Letter |
|
Times cited : (141)
|
|
References (5)
|
